Law firm Levi & Korsinsky has filed a class action lawsuit against Neumora Therapeutics (NMRA) alleging the company made false statements about its Phase Two clinical trials for Navacaprant, a therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit claims Neumora manipulated trial inclusion criteria and statistical analysis to show favorable results, potentially misleading investors.